Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Well it's not under a quid yet so you're still right!
We shall see Watching. I'd much rather see the RNS personally.
It's no surprise to me following my recent experience of the urology department in my local NHS hospital. They had no knowledge of the PSE diagnostic test for prostate cancer developed by OBD and now available for use (privately only at the moment) in the UK and the USA, nor had the urologist I saw (who had a string of letters after his name) heard of the Echo laser treatment technique for reducing the pressure on the urethra caused by an enlarged prostate. He didn't believe me until he googled it on his phone in my presence! Having said this, a good mate is now in remission from bladder cancer following treatment at the same hospital. He's a lucky man as he left it late to present with the symptoms. Guys, get the message; if things don't seem right get yourself tested and get it picked up early. You owe it to your families
If you have faith in the IP, and can afford to wait, the current SP looks a bargain. From experience of AIM, it could become even more of a bargain as concerns over funding the programmes grow. If I was a younger person, with funds available I would be adding cautiously at this stage and using pound cost averaging.
Hi Donkey,
I personally think that my biopsy was unnecessary but I had different opinions from two urologists following an MRI scan and I went with the view of the NHS guy as the procedure was offered under the NHS. The existence of the PSE test (then) would have avoided what is an invasive process with a corresponding risk of infection. My post procedure experience was not as severe as your friend's but it did result in an overnight stay in hospital for observation. I imagine that adoption by the NHS, as part of a screening program, would substantially lower the cost of the PSE test but I doubt it will happen in my lifetime.
Hi Thorn,
Thanks for your post and you are clearly better informed than most men on this subject. I agree with you that the PSA test is not fit for purpose on its own and also agree that men over the age of 70 need to adopt a different attitude to the risk than men in their 40s and 50s who may have concerns about changes they notice, symptoms etc. I think the point is that this new PSE test, alongside the standard PSA test, should give more accurate diagnosis and avoid unnecessary MRI scans and biopsies. It's been developed by a British biotech (over a 10 year period)and was validated in the USA so perhaps it's a apt precedent for AVCT. Let's hope so.
I can't go along with your "advice" Thorn. I have 5 friends or family members that have been treated successfully for prostate cancer and their success was due to early detection following testing under the current flawed system. One was in his early 50s and two were under 70.
What we need to be pushing for is a screening program to be introduced in the UK based on the two blood tests PSA and PSE. If the UK Government committed to same then many lives would be saved through early diagnosis and appropriate treatment. I would argue that there would also be a significant overall cost benefit due to a saving on the cost of unnecessary MRI scans and biopsies under the NHS
Well to be honest Bella, until this British biotech company test was developed and became available, the diagnostic procedure was eye watering, expensive and, quite often unnecessary. I can testify to this from personal experience. Unfortunately, again from personal experience, healthcare professionals here in the UK are often completely unaware of the diagnostic and therapeutic advances that have been made recently. If my post helps one guy avoid what I had to go through to have a negative cancer diagnosis then it will have been worthwhile. Thanks for your festive greetings and mine go to all posters, even the abusive ones!
Apologies for the off topic post but hopefully more accurate and earlier diagnosis will enable drugs using AVCT technology to be even more effective for men now in their 30s and 40s.
A relatively recently approved blood test, called a PSE test, is now available for use in the USA and the UK. It improves the accuracy of a standard PSA test from 55% to 94%.
It's not available on the NHS but is available privately at a cost of £750. This compares very favourably to the private costs of an MRI scan and a biopsy of the prostate. More information is available on www.94percent.com
Will the SP react on phase 1a data release or will it need positive peer review first?
Surely what will be required to move the SP up will be positive news concerning the ongoing funding needs i.e. licensing deal(s), a buyout offer for one or both divisions or something else that sparks the interest of institutional Investors. FDA approval would help.
Or should that be a large fortune!
Might have saved the taxpayer a small fortune too NY!
Meant to say "development of the platform to stall"
Personally, I would prefer AVCT to remain independent and to fund the development of a major new British biotech company via license deals. AS won't allow the development of the platform if he's in the driving seat. I remain suspicious of the motives of BP and their willingness to push forward with the costs of development against their vested interests in protecting income streams from drugs already on the market. Maybe a cynical view of BP?
DTW, when you consider what the SP was in February and where it is now following the stunning RNS last Tuesday, there has to be an explanation for the less than stellar rise in the SPand the lack of follow through post RNS. The CEO's past track record has to be considered a possible factor wouldn't you agree? There's also the question of uncertainty over the possibility of a further fundraise, the timing and the level of this. The SP will remain constrained until the uncertainties are removed but it remains an excellent risk reward speculative bet at this point in time.
Couldn't agree more Ice. They will soon be awash with cash and this will almost certainly be the last time that they will be required to pay off part of the loan with shares. I think Wyn will be proved correct about the extent of today's profit taking pullback. Tomorrow awaits!
Thanks for sharing that Wyn. I will need a bigger pullback to follow your lead but maybe the Yanks will see a bargain and do the same this pm?
I would think that the requirement for additional funding is certain. However the amount, timing and level of this isn't. With today's news I would expect the fundraising to be at a significantly higher level than 95p. This is amazing news for all cancer patients for the future and the current SP simply doesn't reflect this. Well done to the Avacta team.
I asked a family member who he fancied to win the Open at Hoylake last month, knowing that he likes a gamble. He reeled off about 5 names (all long shots). He placed £20 to win on each of the 5 players, including Brian Harman at 170-1. I have to confess that, like probably 95% of the British public, I'd not heard of Harman even though I do like golf.
The family member in question had done his homework however and knew Harman was "under the radar" so to speak.
He was able to lay off part of the bet when Harman led the tournament after 2 rounds and left the rest for his eventual payday.
As the rumours start to arrive I reckon we'll see a lot of investors in Avacta (aka Gamblers) doing exactly that i.e. laying off their bets and leaving the rest for the bumper payday. It will surely be volatile as the data is released and the SP reacts.
I reckon 95% of the gamblers on here i.e. all of us would bite the hand off for £2 a share right now but those in the know will hold for gold. GLA
Very well put Nicepair. It certainly doesn't appear that Myles' latest ramp has had any impact. The SP seems certain to drift down until we get some positive news but it could then turn dramatically of course. Oh well, "sell in May and go away" as they say.